End of the Transition Period for companies subject to Cosmetics Regulation in Switzerland
In June 2014, Switzerland launched Project LARGO and changed its regulation in order to harmonize it with the European Union (EU) and simplify trade procedures. Several transition periods were granted. Presently, the obligation to provide a safety assessment report for each cosmetic product, create a Product Information File, and to follow Good Manufacturing Practices (GMP) has already come into force.

COSMETICS REGULATION IN SWITZERLAND AND PROJECT LARGO

Switzerland is a member of the European Free Trade Association (EFTA) but it is not a participant of the Agreement on the European Economic Area (EEA). In Switzerland, cosmetic products need to be in compliance with the Federal Office for Food Safety and Veterinary Affairs (OSAV).

Project LARGO (2014) was developed as an effort to adjust the legal framework and had as main goals: guarantee food safety (top priority and to match EU safety level); break down trade barriers with the EU; and create conditions to participate in safety systems run by the EU (RASFF, RAPEX, EFSA). Harmonization with the EU Cosmetic Regulation was the central objective of Swiss Regulation changes.

On May 1st 2017, ordinance on foodstuffs and consumer goods and ordinance on cosmetic products entered into force. These ordinances set up some requirements for cosmetic products similar to the ones present in the European Regulation.

According to the Federal Act on Foodstuffs and Utility Articles (Foodstuffs Act, FSA, 817.0) cosmetics are considered utility articles (and not foodstuffs) which, when used as normally intended, externally come into contact with the body, teeth or mucous membranes. The same act says that it must be possible to trace cosmetics at all levels of production, processing and distribution phases.

HARMONIZATION WITH THE EU REGULATION

The Safety Assessment Report necessary for cosmetic products must obey to the same standards in Switzerland and the EU (European Cosmetics Regulation (EC) No. 1223/22009). It needs to have a part A (information regarding the product and formula) and a part B (safety assessment details such as warnings, conclusions and reasoning, and information about the safety assessor who performed it).

The Federal Council may stipulate further requirements for cosmetic products and recommends following Good Manufacturing Practices (GMP). Cosmetic products must comply with the lists of regulated substances and have a Product Information File (PIF). Advertising, labelling and forbidding deception are also regulated and included in the ordinance. Moreover, if the final formulation or ingredients of cosmetics have been tested in animals, the Federal Council may restrict or prohibit the placing on the market of such cosmetics (in order to comply with foodstuff legislation).

Ingredients present in cosmetic products made available on the Swiss market need to comply with the Annexes of the European Regulation (EC) No. 1223/2009. Nevertheless, the Federal Department of Home Affairs may establish exemptions.

Despite the similarities, Swiss regulation is still different from the EU. For example, artisanal cosmetic products sold locally (which are not intended for children) do not need to have a PIF. Although the address of the EU Responsible Person (RP) may be put on the label, the responsibility to ensure compliance with Swiss Regulation is attributed to the manufacturer/importer (which needs to be designated for each cosmetic product made available on the market and they may not delegate this responsibility to an EU RP or any other legal person abroad).

As part of the harmonization with EU Cosmetic Regulation, several deadlines were set. The obligation to provide a safety assessment report for each cosmetic product, create a Product Information File, and to follow Good Manufacturing Practices (GMP), has come into force since the 30th of April, 2021. This date represented the last deadline for the harmonization process.

With the LARGO Project and the harmonization of its Regulation with the European Union, Switzerland aims to achieve the same level of protection for consumers as seen in the EU. Cosmetic products made available in the Swiss market must comply with the lists of regulated substances, labelling, and the obligations defined in the EU Cosmetic Regulation. Switzerland also follows the same 6 common criteria set out in the Commission Regulation (EU) No 655/2013 regarding the justification of cosmetic claims.

Compliance with different Regulations can be a challenge and it is important to be up to date. Critical Catalyst is available to help you, wherever you wish to place your cosmetic products. For more information bout Switzerland requirements and other enquiries, feel free to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. Federal Assembly of the Swiss Confederation – Federal Act on Foodstuffs and Utility Articles (Foodstuffs Act, FSA) of 20 June 2014 (Status as of 1 May 2021)
  3. Swiss Federal Council – Ordinance on the Use of Swiss Indications of Source for Cosmetic Products of 23 November 2016 (Status as of 1 January 2017)
  4. Conseil Fédéral Suisse – Ordonnance sur les denrées alimentaires et les objets usuels, du 16 décembre 2016 (Etat le 1er juillet 2020)  

further
reading

cosmetic products

Citral under review: SCCS Preliminary Opinion

The SCCS was tasked by the European Commission to evaluate if the safety levels for Citral, determined through QRA2 based on skin sensitization induction, are sufficient to safeguard consumers. A preliminary opinion was released.

Read More »
cosmetic products

Are sunscreens with Benzophenone-4 safe?

Benzophenone-4 is commonly known as a UV-filter in cosmetic products. Learn what the final opinion of SCCS states about Benzophenone’s safety profile as a UV-filter in cosmetic products.

Read More »
cosmetic products

Is Aluminium in cosmetics safe for human health?

The Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Aluminium in cosmetic products. This follows a lengthy review process that began in 2013 when the SCCS was first mandated to evaluate the potential health risks of Aluminium (Al) and its compounds in cosmetics.

Read More »
cosmetic products

Silver in Cosmetics: SCCS preliminary opinion.

Ingredients: SILVER

The recent preliminary opinion from the Scientific Committee on Consumer Safety (SCCS) regarding silver in cosmetics is crucial for consumers and manufacturers. This article breaks down the key points, making it easier to understand the implications and stay informed.

Read More »
news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »